With the new venture fund, Praxis aims to raise $5 million in its initial stage, with a longer-term target of $20 million, ...
Blackstone acquired Precision Medicine Group from Berkshire Partners and TPG Growth for between $2.3bn and $2.4bn in late ...
A joint research team led by Dr. Jeong Sohee from the Center for Extreme Materials Research at KIST and Dr. Lee Kwang-hee ...
Experienced R&D leader with a track record of advancing innovative therapies from early development to global approval - ...
Tech Xplore on MSN
Lithium-air batteries break performance barriers thanks to a newly developed 2D catalyst
As the electric vehicle and energy storage system (ESS) markets experience rapid growth, the development of next-generation ...
Tech Xplore on MSN
Breaking fuel cell barriers: New platinum catalyst brings high-efficiency hydrogen vehicles closer to commercialization
A research team has developed a next-generation platinum-based catalyst that improves both activity and durability in ...
Includes novel proteomic and genomic approaches to oncology therapeutic selection, response monitoring, and Molecular Residual Disease (MRD) testing ...
HSSA Funding to Support Commercialization of Biological Testing Platform and High-Paying Bioscience Jobs in Spokane ...
Research Manitoba has launched a new Intellectual Property (IP) division and appointed Dr. Jody Dexter as its inaugural ...
BTQ Technologies has appointed Dr. Ro Cammarota to its U.S. team to help accelerate the development, commercialization, and ...
Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that the company will present seven abstracts, including two oral sessions, ...
Experienced R&D leader with a track record of advancing innovative therapies from early development to global approval - RESEARCH TRIANGLE PARK, N.C., April 06, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results